Testing a new cell therapy for blood cancers that have stopped responding to other treatments

This trial is testing LV009 Injection, a new type of treatment that uses your own immune cells (called T cells) to fight blood cancers like lymphoma and leukemia that have come back or stopped responding to other treatments. Researchers will give different groups of patients different doses of this medication to find out which dose works best and is safest. The goal is to understand whether this treatment can help patients whose cancer has become difficult to treat.

Many patients with blood cancers have limited options when their cancer comes back or stops responding to standard treatments. This medication represents a new approach using the body's own immune system to attack cancer cells, and this trial will help determine if it can offer hope to patients who need new options.